| Literature DB >> 33407864 |
Zhuangzhuang Xiao1, Tong Lei1, Yanyan Liu2, Yanjie Yang1, Wangyu Bi1, Hongwu Du3.
Abstract
Parkinson's disease (PD), the second most common neurodegenerative disease worldwide, is caused by the loss of dopaminergic (DAergic) neurons in the substantia nigra resulting in a series of motor or non-motor disorders. Current treatment methods are unable to stop the progression of PD and may bring certain side effects. Cell replacement therapy has brought new hope for the treatment of PD. Recently, human dental tissue-derived mesenchymal stem cells have received extensive attention. Currently, dental pulp stem cells (DPSCs) and stem cells from human exfoliated deciduous teeth (SHED) are considered to have strong potential for the treatment of these neurodegenerative diseases. These cells are considered to be ideal cell sources for the treatment of PD on account of their unique characteristics, such as neural crest origin, immune rejection, and lack of ethical issues. In this review, we briefly describe the research investigating cell therapy for PD and discuss the application and progress of DPSCs and SHED in the treatment of PD. This review offers significant and comprehensive guidance for further clinical research on PD.Entities:
Keywords: Cell therapy; Dental pulp stem cells; Dopaminergic neurons; Parkinson’s disease; Stem cells from human exfoliated deciduous teeth
Mesh:
Year: 2021 PMID: 33407864 PMCID: PMC7789713 DOI: 10.1186/s13287-020-01957-4
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832